The costs of head and neck oncology: Primary tumours, recurrent tumours and long-term follow-up

M. Van Agthoven*, B. M. Van Ineveld, M. F. De Boer, C. R. Leemans, P. P. Knegt, G. B. Snow, C. A. Uyl-De Groot

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review


We retrospectively calculated the costs of head and neck oncology for reimbursement purposes. This analysis was based on 854 head and neck cancer patients treated between 1994 and 1996 in two major Dutch university hospitals. To anticipate future care costs, costs of required improvements in the quality of care were added. Costs of diagnosis, treatment and 2 years of follow-up of patients with a primary tumour were €21 858. For patients with a recurrent tumour, this amount was €27 629. The costs of 10 years of follow-up were €423 after discounting and correction for survival. In total, average costs per new patient were €31 829, which covered discounted costs of treating the primary tumour, costs of treating recurrent tumours in 40% of all patients and the costs of 10 years of follow-up. Costs of improving the quality of care were estimated to be €1598 per new patient.

Original languageEnglish
Pages (from-to)2204-2211
Number of pages8
JournalEuropean Journal of Cancer
Issue number17
Publication statusPublished - 2001

Cite this